Ptmscan® Results, Phospho-PKA Substrate Motif (RRXS*/T*)

Ptmscan® Results, Phospho-PKA Substrate Motif (RRXS*/T*)

Table: PTMScan® Results, Phospho-PKA Substrate Motif (RRXS*/T*), label-free quantitation Study design: rat cell line PC-12; Trypsin digest; Antibody: Phospho-PKA Substrate Motif (RRXS*/T*), PTMScan® Kit #1984, #5565 Treatments: Untreated, forskolin treated Fold-Change Index (Forskolin/Untreated) Protein Name Phosphorylation Site Description Peptide Accession kD Count in Study Intensity (Untreated) 3 Adaptor/scaffold 4 10.4 AHNAK 159 PREDICTED: similar to AHNAK nucleoprotein isoform 1 isoform 1 RVtAYTVDVTGR XP_574618 581 2 8.69E+05 5 11.2 AHNAK 161 PREDICTED: similar to AHNAK nucleoprotein isoform 1 isoform 1 RVTAyTVDVTGREGVKDIDISSPE XP_574618 581 1 6.14E+04 6 2.8 AKAP1 101 A-kinase anchor protein 1 RRsESSGNLPSIVDTR O88884 92 1 2.49E+06 7 2.2 AKAP2 850 A kinase (PRKA) anchor protein 2 RKsALALRWE Q5U301 96 1 5.57E+05 8 6.7 AP3D1 754, 758, 760 adaptor-related protein complex 3, delta 1 subunit RHsSLPtEsDEDIAPAQRVDIITE XP_234908 136 1 5.47E+04 9 3.2 AP3D1 754, 760 adaptor-related protein complex 3, delta 1 subunit RHsSLPTEsDEDIAPAQRVDIITE XP_234908 136 1 3.61E+05 10 -6.2 CTNND1 320 catenin (cadherin associated protein), delta 1 LRsYEDM#IGEEVPPDQYYWAPLAQHE XP_001064294 105 1 5.76E+05 11 3.8 DOCK1 1756 dedicator of cyto-kinesis 1 RFsVSPASPCSQPTPPPVTPR NP_001137330 215 1 1.01E+06 12 1.7 FNBP1L 488 formin binding protein 1-like RHsSDINHLVTQGRESPE Q2HWF0 70 1 3.98E+05 13 -1.2 FRS2 132, 135, 138 fibroblast growth factor receptor substrate 2 LEVPRtPRtPTtPGLGAQSLPNGYPR EDM16633 57 2 2.59E+05 14 2.2 FRS2 428 fibroblast growth factor receptor substrate 2 DCTPTVFNFDIRRPsLE EDM16633 57 1 8.14E+05 15 3.2 IRS-2 557 PREDICTED: similar to Insulin receptor substrate 2 (IRS-2) (4PS) RVsGDGAQDLDR O70360 137 1 1.75E+05 16 2.4 MPDZ 1802 multiple PDZ domain protein IKAAPFHSERRPsQSSQVSE O55164 219 1 2.14E+06 17 1.4 MPDZ 1802, 1804, 1808 multiple PDZ domain protein IKAAPFHSERRPsQsSQVsE O55164 219 1 5.29E+05 18 2.3 MPDZ 1804, 1805 multiple PDZ domain protein AAPFHSERRPSQssQVSE O55164 219 1 5.37E+05 19 4.5 MTSS1 307 metastasis suppressor 1 KSsVCSSLNSVNSSDSR NP_001124035 86 1 2.74E+05 20 9.5 Nck1 21 NCK adaptor protein 1 RKPsVPDTASPADDSFVDPGER XP_217246 36 3 2.51E+05 21 2.1 PARD3 715 partitioning-defective protein 3 homolog RIsHSLYSGIE Q9Z340 149 1 3.76E+05 22 2.2 LIM 228 PDZ and LIM domain 5 RGsQGDIKQQNGPPR Q62920 63 4 2.01E+06 23 3.4 tensin 3 648 PREDICTED: similar to tensin-like SH2 domain containing 1 KPsAPTPTQAYGQSNYSTQTWVR XP_341257 117 1 1.16E+05 26 23.6 14-3-3 zeta 58 tyr 3-monooxygenase/tryp 5-monooxygenase activation prot, zeta polypep RSsWRVVSSIEQKTE P63102 28 2 2.02E+05 27 Adhesion or extracellular matrix protein 28 2.5 CTNNB1 552 beta-catenin RTsMGGTQQQFVE Q9WU82 85 2 2.91E+06 29 1.1 desmoplakin 174 PREDICTED: similar to desmoplakin isoform II isoform 1 RAsSKGGYTCQSGSGWDE Q4QQR7 332 2 5.62E+06 30 -2.6 desmoplakin 174, 175 PREDICTED: similar to desmoplakin isoform II isoform 1 RAssKGGYTCQSGSGWDE Q4QQR7 332 1 2.60E+05 31 1.2 desmoplakin 175 PREDICTED: similar to desmoplakin isoform II isoform 1 VRRASsKGGYTCQSGSGWDE Q4QQR7 332 1 4.87E+06 32 1.8 desmoplakin 56 PREDICTED: similar to desmoplakin isoform II isoform 1 RCtVNDQNSDGYCQTGTM#SR Q4QQR7 332 1 1.18E+05 33 -2.3 LAD1 62 ladinin SVERLPsVEEAE NP_001101412 57 1 1.17E+06 34 -1.4 Nogo iso2; Nogo 107; 107 Reticulon-4 GPLPAAPPAAPERQPsWE Q9JK11-2; Q9JK11 39; 126 2 1.92E+07 35 10.7 plakophilin 3 159 plakophilin 3 RLsSAHNGGSAFGAVGYGGAQPTPPM#PTRPVSFHE NP_001099785 90 4 6.07E+05 36 1.2 plakophilin 3 159, 188 plakophilin 3 RLsSAHNGGSAFGAVGYGGAQPTPPM#PTRPVsFHE NP_001099785 90 1 5.02E+05 37 Apoptosis 38 9.9 EI24 46 etoposide induced 2.4 mRNA RAsSLLAQR Q4KM77 39 1 1.31E+05 39 1.3 PAR-4 155 PRKC, apoptosis, WT1, regulator RStGVVNIPAAECLDEYEDDE Q62627 36 1 6.74E+05 40 -2.7 PEA-15 116 phosphoprotein enriched in astrocytes 15A YKDIIRQPsEEE Q5U318 15 1 1.54E+06 41 Cell cycle regulation 42 3.7 AFAP1L2 341 PREDICTED: similar to Protein KIAA1914 KKsTSLEPPDRSLE XP_217643 92 1 4.05E+05 43 3.4 CLASP1 600 rCG37592 SRsDIDVNAAASAK EDL87905 167 2 1.02E+06 44 6.0 CLASP1 658 rCG37593 TRRQsSGSTTNVASTSSDSR EDL87905 167 5 2.93E+05 45 6.0 CLASP1 658, 661 rCG37594 RQsSGsTTNVASTSSDSR EDL87905 167 1 8.97E+04 46 2.4 CLASP1 690 rCG37595 sSSPGKLLGSGYGGLAGGSSRGPPVTPSSE EDL87905 167 1 9.95E+05 47 3.9 CLASP1 692 rCG37596 SSsPGKLLGSGYGGLAGGSSR EDL87905 167 1 2.38E+05 48 7.7 B99 501 G-2 and S-phase expressed 1 RLsGLTPQGLPSSM#R XP_217016 80 2 1.78E+05 49 1.6 KAB1 968 rCG20491, isoform CRA_b IRQPsIDLTDDDQTSSVPHSAISDIMSSDQE EDL94780 170 1 2.35E+05 50 -1.1 NuMA-1 337 PREDICTED: similar to nuclear mitotic apparatus protein 1 isoform 1 RRtTQIINITMTK Q4G051 71 1 4.21E+05 51 5.0 NUSAP1 113 nucleolar and spindle associated protein 1 RRDsTTFQNQE NP_001101232 43 3 9.67E+05 52 2.5 NUSAP1 115 nucleolar and spindle associated protein 1 M#KRRDSTtFQNQE NP_001101232 43 1 4.79E+04 53 2.4 MCC 354 PREDICTED: mutated in colorectal cancers KKsSCSLSVAE XP_225962 112 1 4.00E+05 54 2.6 MCC 354, 355 PREDICTED: mutated in colorectal cancers KKssCSLSVAE XP_225962 112 1 6.54E+05 55 3.9 SPECC1L 833 SPECC1-like RSsTSSEPTPTVK Q2KN99 124 3 3.30E+06 56 14.1 SPECC1L 833, 836 SPECC1-like RSsTSsEPTPTVK Q2KN99 124 1 4.98E+04 1 LEGEND: * = phosphorylation; # = oxidized methionine, fold changes greater than 5 upon drug treatment are highlighted Table: PTMScan® Results, Phospho-PKA Substrate Motif (RRXS*/T*), label-free quantitation Study design: rat cell line PC-12; Trypsin digest; Antibody: Phospho-PKA Substrate Motif (RRXS*/T*), PTMScan® Kit #1984, #5565 Treatments: Untreated, forskolin treated Fold-Change Index (Forskolin/Untreated) Protein Name Phosphorylation Site Description Peptide Accession kD Count in Study Intensity (Untreated) 57 Chaperone 58 12.1 HSP20 16 heat shock protein, alpha-crystallin-related, B6 RAsAPLPGFSTPGR P97541 18 1 3.86E+05 59 Chromatin, DNA-binding, DNA repair or DNA replication protein 60 1.9 capicua 1394, 1405 capicua homolog KNsTDLDSAPEDPtSPKRK NP_001100960 164 2 1.06E+06 61 45.7 H1C 36 histone cluster 1, H1d KAsGPPVSE P15865 22 9 1.08E+05 62 -1.7 LBR 101 lamin B receptor SVsASYQADAKEKE O08984 71 1 2.70E+05 63 2.9 polybromo 1 39 PREDICTED: similar to polybromo 1 isoform 2 isoform 1 RLsSLPTVDPIAVCHE XP_001059112 181 1 9.24E+05 64 4.0 TERF2IP 43 telomeric repeat binding factor 2, interacting protein RLsTLILHGGGILCR Q5EAN7 43 1 4.59E+05 65 5.8 TTF1 103 PREDICTED: similar to transcription termination factor 1 RREsQTPAQENLE XP_001079280 96 1 8.21E+04 66 Cytoskeletal protein 67 51.5 cordon-bleu 1042 cordon-bleu homolog KVsSLASEE NP_001100706 122 1 5.88E+04 68 -1.6 cordon-bleu 219 cordon-bleu homolog KSsLGNDETDKE NP_001100706 122 2 1.02E+04 69 3.3 cordon-bleu 648 cordon-bleu homolog RNsMEKYLNGPAE NP_001100706 122 1 4.21E+05 70 7.9 DAL-1 423 erythrocyte protein band 4.1-like 3 RAsALIDRPAPYFE Q9JMB3 122 1 2.41E+05 71 1.9 EPPK1 2290, 2709, 3224 PREDICTED: similar to Epiplakin AQAATGFIIDPVHNRRLsVEE XP_001059215 370 1 6.03E+05 72 6.4 FLNB 2107 filamin, beta TSRAPsVATVGSICD XP_224561 278 1 2.27E+05 73 1.5 FNBP1 496 formin binding protein 1 RQsGLYDGQTHQTVTNCAQDRE Q8R511 71 2 1.65E+05 74 3.7 KIF23 903 kinesin family member 23 RsSTLAPAQPDGTESE NP_001101625 109 1 3.07E+05 75 1.1 KIF23 903, 904 kinesin family member 23 KRRssTLAPAQPDGTESE NP_001101625 109 1 4.28E+05 76 4.7 KIF23 904 kinesin family member 23 RSsTLAPAQPDGTESEWTDVE NP_001101625 109 2 3.80E+05 77 5.7 KIF23 905 kinesin family member 23 RSStLAPAQPDGTE NP_001101625 109 2 1.32E+06 78 -7.6 K14 40 keratin 14 M#SSVLAGGSCRAPsTYGGM#SR Q6IFV1 53 2 1.03E+06 79 -2.8 K14 42 keratin 14 M#SSVLAGGSCRAPSTyGGMSR Q6IFV1 53 1 7.33E+05 80 -1.9 eplin 225 PREDICTED: similar to Epithelial protein lost in neoplasm (mEPLIN) RLsENSCSLDDLE Q6J4T4 84 2 1.83E+06 81 -1.1 nestin; nestin iso2 1166; 1078 nestin RKsIDTQEPLWSTE P21263; P21263-2 209; 199 1 9.61E+06 82 -1.6 plectin 1 4641, 4645 plectin 1 AGsRRGsFDATGSGFSM#TFSSSSYSSSGYGR P30427 534 1 3.22E+05 83 -3.0 plectin 1 4645 plectin 1 RGsFDATGSGFSM#TFSSSSYSSSGYGR P30427 534 2 2.12E+06 84 1.3 RIL 119 reversion induced LIM RSsISGISLE P36202 36 1 2.02E+07 85 71.4 KIF13B 1718, 1719 kinesin 13B RRssGLQPQGAPE Q70AM4 197 1 9.17E+04 86 Enzyme, misc. 87 3.7 CPOX 117 coproporphyrinogen oxidase RCsTFM#SSPVTE Q3B7D0 49 1 1.25E+05 88 2.9 GYS1 709 glycogen synthase 1 (muscle) sNSVDTGPSSSLSTPTEPLSPTSSLGEERN A2RRU1 84 1 3.79E+05 89 2.4 HELZ 1785 helicase with zinc finger domain RIsSGAAQPCVEE NP_001099318 220 1 4.35E+06 90 3.4 HMGCS1 471 hydroxymethylglutaryl-CoA synthase 1 TYARRPsTNDHSLDE P17425 57 2 3.55E+06 91 3.5 UQCRC1 214 ubiquinol-cytochrome c reductase core protein I RLSRtDLTDYLSR Q68FY0 53 1 1.45E+06 92 G protein or regulator 93 -1.0 ARF GAP1 360 ADP-ribosylation factor GTPase activating protein 1 RSsDSWDIWGSGSASNNKNSNSDGWE Q62848 45 1 6.01E+05 94 7.4 ARHGAP17 710 nadrin RCsSSLPPIQAPNHPPPQPPTQPR Q99N37 94 1 6.31E+05 95 4.7 ARHGAP17 712 nadrin RCSSsLPPIQAPNHPPPQPPTQPR Q99N37 94 1 7.61E+05 96 4.0 ARHGAP23 790 PREDICTED: similar to Rho GTPase activating protein 21 HYsQDCSSIKAGR XP_220918 177 1 1.13E+05 97 -1.1 ARHGEF5 1079 PREDICTED: similar to rho guanine nucleotide exchange factor 5 isoform 1 RCsKLINSSQLLYQE XP_342677 177 1 5.87E+05 98 6.4 ARPP-19 104 cyclic AMP phosphoprotein VTGDHIPTPQDLPQRKPsLVASKLAG Q712U5 12 10 8.48E+06 99 8.5 DOCK6 41 dedicator of cytokinesis 6 RSSsSLGVPLTE NP_001102467 202 1 8.55E+05 100 1.1 RalGAPA1 753 PREDICTED: similar to GTPase activating RANGAP domain-like 1 isoform 3 SIVRQKtVDIDDSQILPR O55007 234 1 2.95E+05 101 -1.4 RalGAPA1 772 PREDICTED: similar to GTPase activating RANGAP domain-like 1 isoform 3 VRHFsQSEDTGNE O55007 234 1 1.78E+05 102 -1.4 GIT2 614 G protein-coupled

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    7 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us